생약학회지 (Korean Journal of Pharmacognosy)

  • 제46권4호
  • /
  • Pages.327-333
  • /
  • 2015
  • /
  • 0253-3073(pISSN)
  • /
  • 2288-9299(eISSN)
한국생약학회 (The Korean Society of Pharmacognosy)
권호 표지

모과 에탄올 추출물의 아세틸콜린에스테라제 저해활성과 신경세포에서 아밀로이드 전구단백질의 대사에 미치는 영향

The Acetylcholinesterase Inhibitory Activity of the EtOH Extract of Chaenomelis Fructus and its effects on the Metabolism of Amyloid Precursor Protein in Neuroblastoma Cells

  • 투고 : 2015.12.02
  • 심사 : 2015.12.15
  • 발행 : 2015.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Alzheimer's disease (AD) is a progressive neurodegenerative disorder symptomatically characterized by impairment in memory and cognitive abilities. AD is characterized pathologically by the deposition of ${\beta}$-amyloid ($A{\beta}$) peptides of 40-42 residues, which are generated by processing of amyloid precursor protein (APP). $A{\beta}$ has been believed to be neurotoxic and now is also considered to have a role on the mechanism of memory dysfunction. In this study, we tested that EtOH extract of the fruits of Chaenomeles sinensis Koehne (CSE) affects on the processing of APP from the APPswe over-expressing Neuro2a cell line. We found that CSE increased over 2 folds of the $sAPP{\alpha}$ secretion level, a metabolite of ${\alpha}$-secretase. We showed that CSE reduced the secretion level of $A{\beta}42$ and $A{\beta}40$ by down regulation of ${\beta}$-secretase (BACE) without cytotoxicity. Furthermore, we found that CSE inhibited BACE and acetylcholinesterase activity in vitro. We suggest that Chaenomelis Fructus may be an useful source to develop a herbal medicine for AD.

키워드

참고문헌

  1. 통계청 자료(http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B35001).
  2. Morris, J. C. (1996) Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165: 41-50.
  3. Selkoe, D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8: 447-453. https://doi.org/10.1016/S0962-8924(98)01363-4
  4. Strittmatter, W. J., Weisgraber, K. H. Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102. https://doi.org/10.1073/pnas.90.17.8098
  5. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A .D., Haines, J. L. and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. https://doi.org/10.1126/science.8346443
  6. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G. and Citron, M. (1999) ${\beta}$-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741. https://doi.org/10.1126/science.286.5440.735
  7. Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31. https://doi.org/10.1038/19866
  8. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L. and Wong, P. C. (2001) BACE1 is the major ${\beta}$-secretase for generation of $A{\beta}$ peptides by neurons. Nature Neurosci. 4: 233-234. https://doi.org/10.1038/85064
  9. Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C. S., Pang, Y., Youdim, M. B. and Han, Y. (2009) Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Eur. J. Pharmacol. 623: 14-21. https://doi.org/10.1016/j.ejphar.2009.09.013
  10. Sugimoto, H. (2001) Donepezil hydrochloride. a treatment drug for Alzheimer's disease. Chem. Rec. 1: 63-73. https://doi.org/10.1002/1528-0691(2001)1:1<63::AID-TCR9>3.0.CO;2-J
  11. Zarotsky, V., Sramek, J. J. and Cutler, N. R. (2003) Galantamine hydrobromide. an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60: 446-452.
  12. Jann, M. W. (2000) Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12. https://doi.org/10.1592/phco.20.1.1.34664
  13. 대한약전외한약(생약)규격집.
  14. 배기환 (2001) 한국의 약용식물, 212-213, 교학사, 서울.
  15. 박종희 (2012) 대한약초백과도감, 628-629, 신일북스, 서울.
  16. Hamaza, Y., Irie, M, Kondo, M. and Fugita, T. (2008) Antiulcerative properties of crude polyphenols and juice of apple, and chinese quince extracts. Food Chem. 108: 488-495. https://doi.org/10.1016/j.foodchem.2007.10.084
  17. Jung, MH., Song, KS. and Seong, YH. (2012) Inhibitory Effect of Chaenomeles sinensis Fruit on Amyloid ${\beta}$ Protein (25-35)-Induced Neurotoxicity in Cultured Neurons and Memory Impairment in Mice. 20: 8-15. https://doi.org/10.7783/KJMCS.2012.20.1.008
  18. Wang, R., Sweeney, D., Gandy, S. E. and Sissodia, S. S. (1996) The profile of soluble amyloid ${\beta}$ protein in cultured cell media. J. Biol. Chem. 271: 31894-31902. https://doi.org/10.1074/jbc.271.50.31894
  19. Harun A., Muhammad J. J. R., Lim S. M, Bakar A. M. A., Cole A. L. J. and Ramasamy K. (2011) BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plants. BMC Complement Altern. Med. 11: 79. https://doi.org/10.1186/1472-6882-11-79
  20. Leem, J. Y., Saura, C. A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L. T., Veselits, M. L., Tomita, T., Gasparini, L., Iwatsubo, T., Xu, H., Green, W. N., Koo, E. H. and Thinakaran, G. (2002) A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11: 64-82. https://doi.org/10.1006/nbdi.2002.0546
  21. Tung, J. S., Davis, D. L., Anderson, J. P., Walker, D. E., Mamo, S., Jewett, N., Hom, R. K., Sinha, S. and Thorsett, E. D., John, V. (2002) Design of substrate-based inhibitors of human beta-secretase. J. Med. Chem. 45: 259-262. https://doi.org/10.1021/jm0155695
  22. Iqbal, K., Sisodia, S. S. and Winblad, B. (2001) Alzheimer's disease. Advances in etiology, pathogenesis and therapeutics. John Wiley & Sons, Ltd.
  23. Li, N., Zhou, L., Li, W., Liu, Y., Wang, J. and He, P. (2015) Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: A metabolomics study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 985C: 54-61.
  24. Uchida, N., Takasaki, K., Sakata, Y., Nogami, A., Oishi, H., Watanabe, T., Shindo, T., Egashira, N., Kubota, K., Katsurabayashi, S., Mishima, K., Fujiwara, M., Nishimura, R. and Iwasaki, K. (2013) Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease. Phytother. Res. 27: 966-972. https://doi.org/10.1002/ptr.4818
  25. Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. (2002) PEN-2 is an integral component of the ${\gamma}$-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277: 39062-39061. https://doi.org/10.1074/jbc.C200469200
  26. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. https://doi.org/10.1126/science.1072994
  27. Sambamurti, K., Hardy, J., Refolo L. M. and Lahiri, D. K. (2002) Targeting APP metabolism for the treatment of Alzheimer's disease. Drug Dev. Res. 56: 211-227. https://doi.org/10.1002/ddr.10077
  28. Skovronsky, D. M., Moore, D. B., Milla, M. E., Doms, R. W. and Lee, V. M. (2000) Protein kinase C-dependent alphasecretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J. Biol. Chem. 275: 2568-2575. https://doi.org/10.1074/jbc.275.4.2568
  29. Nunan, J. and Small, D. H. (2000) Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483: 6-10. https://doi.org/10.1016/S0014-5793(00)02076-7
  30. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P. and Selkoe. D. J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3: 67-72. https://doi.org/10.1038/nm0197-67
  31. Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271: 4077-4081. https://doi.org/10.1074/jbc.271.8.4077
  32. Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T. and Iwatsubo, T. (2003) Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. J. Biol. Chem. 278: 18664-18670. https://doi.org/10.1074/jbc.M301619200
  33. Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, M. P. and Tan, J. (2012) Soluble amyloid precursor protein-${\alpha}$ modulates ${\beta}$-secretase activity and amyloid-${\beta}$ generation. Nat. Commun. 3: 777. https://doi.org/10.1038/ncomms1781